Advertisement
Screener

Immune Design Corp. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Immune Design Corp. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2019-04-02: Reporting owner Yurasov Sergey; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2019-04-02: Reporting owner Brady Stephen R; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2019-04-02: Reporting owner Paya Carlos V; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
  • 2019-04-02: Reporting owner ter Meulen Jan Henrik; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2019-04-02Yurasov Sergey
Officer (Sr. VP, Clinic. Devel. & CMO)
4Restricted Stock Units
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−72,620
0 owned after
no price filed2019-04-04
2019-04-02Brady Stephen R
Officer (EVP, Strategy & Finance)
4Restricted Stock Units
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−79,536
0 owned after
no price filed2019-04-04
2019-04-02Paya Carlos V
Director, Officer (President and CEO)
4Restricted Stock Units
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−121,000
0 owned after
no price filed2019-04-04
2019-04-02ter Meulen Jan Henrik
Officer (Chief Scientific Officer)
4Restricted Stock Units
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−69,362
0 owned after
no price filed2019-04-04